Skip to content

Correlation Between Idiopathic Parkinson's Disease and Diabetes Mellitus

Investigation of the Possible Correlation Between Idiopathic Parkinson's Disease and Diabetes Mellitus in Egyptian Elderly Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03685357
Enrollment
120
Registered
2018-09-26
Start date
2018-07-01
Completion date
2020-01-31
Last updated
2018-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observation

Brief summary

Correlation between Idiopathic Parkinson's disease and diabetes mellitus in Egyptian Elderly Patients

Detailed description

1. Record RBDSQ (Rapid eye movement Sleep Behavior Disorder Screening Questionnaire) total score difference between Group 1 and Group 2 . 2. Oral glucose tolerance test will be performed and compared between Group 3 and Group 4. 3. Association between glucose level and motor complication of L-dopa among Idiopathic Parkinson's patients using Unified Parkinson's Disease Rating Scale (UDPRS).

Interventions

None listed

Sponsors

Al-Azhar University
CollaboratorOTHER
Ain Shams University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. Diabetic Patients 2. Idiopathic Parkinsonism

Exclusion criteria

1. Secondary Parkinsonism due to stroke, trauma and encephalitis. 2. Drug induced Parkinsonism.

Design outcomes

Primary

MeasureTime frameDescription
UPDRS (Unified Parkinson's Disease Rating) Scale)BaselineAssociation between glucose level and motor complication of L-dopa among Idiopathic , , Parkinson's patients using Unified Parkinson's Disease Rating Scale (UDPRS)., high scores mean worsen condition
Oral Glucose Tolerance Test0, 0.5 hour , 1 hour, 1.5 hour , 2 hourBetween Idiopathic Parkinson's patients and the Control group
RBDSQ (Rapid eye movement Sleep Behavior Disorder Screening Questionnaire)Baselineamong Diabetic Patients, total score 13 , high scores mean worsen condition

Countries

Egypt

Contacts

Primary ContactAfnan Elgnainy
Afnan.elgnainy@pharma.asu.edu.eg01061840761

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026